Literature DB >> 33727603

Effects of vitamin D deficiency on the improvement of metabolic disorders in obese mice after vertical sleeve gastrectomy.

Jie Zhang1,2, Min Feng3, Lisha Pan4, Feng Wang1,3, Pengfei Wu4, Yang You4, Meiyun Hua4, Tianci Zhang4, Zheng Wang5, Liang Zong6, Yuanping Han7, Wenxian Guan8,9.   

Abstract

Vertical sleeve gastrectomy (VSG) is one of the most commonly performed clinical bariatric surgeries for the remission of obesity and diabetes. Its effects include weight loss, improved insulin resistance, and the improvement of hepatic steatosis. Epidemiologic studies demonstrated that vitamin D deficiency (VDD) is associated with many diseases, including obesity. To explore the role of vitamin D in metabolic disorders for patients with obesity after VSG. We established a murine model of diet-induced obesity + VDD, and we performed VSGs to investigate VDD's effects on the improvement of metabolic disorders present in post-VSG obese mice. We observed that in HFD mice, the concentration of VitD3 is four fold of HFD + VDD one. In the post-VSG obese mice, VDD attenuated the improvements of hepatic steatosis, insulin resistance, intestinal inflammation and permeability, the maintenance of weight loss, the reduction of fat loss, and the restoration of intestinal flora that were weakened. Our results suggest that in post-VSG obese mice, maintaining a normal level of vitamin D plays an important role in maintaining the improvement of metabolic disorders.

Entities:  

Year:  2021        PMID: 33727603      PMCID: PMC7971024          DOI: 10.1038/s41598-021-85531-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  69 in total

1.  Changes in bariatric surgery procedure use in Michigan, 2006-2013.

Authors:  Bradley N Reames; Jonathan F Finks; Daniel Bacal; Arthur M Carlin; Justin B Dimick
Journal:  JAMA       Date:  2014-09-03       Impact factor: 56.272

Review 2.  What is the Mechanism Behind Weight Loss Maintenance with Gastric Bypass?

Authors:  Saurav Chakravartty; Daniele Tassinari; Angelo Salerno; Emmanouil Giorgakis; Francesco Rubino
Journal:  Curr Obes Rep       Date:  2015-06

3.  Iron depletion and repletion with ferrous sulfate or electrolytic iron modifies the composition and metabolic activity of the gut microbiota in rats.

Authors:  Alexandra Dostal; Christophe Chassard; Florentine M Hilty; Michael B Zimmermann; Tanja Jaeggi; Samuela Rossi; Christophe Lacroix
Journal:  J Nutr       Date:  2011-12-21       Impact factor: 4.798

4.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

Authors:  P D Cani; A M Neyrinck; F Fava; C Knauf; R G Burcelin; K M Tuohy; G R Gibson; N M Delzenne
Journal:  Diabetologia       Date:  2007-09-06       Impact factor: 10.122

5.  Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery.

Authors:  Marius Trøseid; Torunn K Nestvold; Knut Rudi; Hanne Thoresen; Erik W Nielsen; Knut T Lappegård
Journal:  Diabetes Care       Date:  2013-07-08       Impact factor: 19.112

6.  Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals.

Authors:  Ling Lu; Zhijie Yu; An Pan; Frank B Hu; Oscar H Franco; Huaixing Li; Xiaoying Li; Xilin Yang; Yan Chen; Xu Lin
Journal:  Diabetes Care       Date:  2009-04-14       Impact factor: 17.152

Review 7.  Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review.

Authors:  Mary N Mugambi; Alfred Musekiwa; Martani Lombard; Taryn Young; Reneé Blaauw
Journal:  Nutr J       Date:  2012-10-04       Impact factor: 3.271

Review 8.  Vitamin D in inflammatory diseases.

Authors:  Thea K Wöbke; Bernd L Sorg; Dieter Steinhilber
Journal:  Front Physiol       Date:  2014-07-02       Impact factor: 4.566

9.  Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice.

Authors:  Lili Ding; Kyle M Sousa; Lihua Jin; Bingning Dong; Byung-Wook Kim; Ricardo Ramirez; Zhenzhou Xiao; Ying Gu; Qiaoling Yang; Jie Wang; Donna Yu; Alessio Pigazzi; Dustin Schones; Li Yang; David Moore; Zhengtao Wang; Wendong Huang
Journal:  Hepatology       Date:  2016-07-25       Impact factor: 17.425

10.  Characterization of a new pathway that activates lumisterol in vivo to biologically active hydroxylumisterols.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Judith V Hobrath; Zorica Janjetovic; Allen S W Oak; Arnold Postlethwaite; Zongtao Lin; Wei Li; Yukimasa Takeda; Anton M Jetten; Robert C Tuckey
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.